Loading...

People

Loading...

Maryam M. Asgari, MD, MPH

Maryam M. AsgariKaiser Permanente Division of Research
2000 Broadway
Oakland, CA 94612

(510) 891-3895 (phone)
maryam.m.asgari@kp.org

Maryam M. Asgari, MD, MPH, is an investigator at the Kaiser Permanente Northern California Division of Research; an associate physician in dermatology at Kaiser Permanente Walnut Creek; and a clinical assistant professor at the University of California, San Francisco. Her research interest is the prevention and treatment of skin cancer. Dr. Asgari received her medical degree from Yale University in 1997; completed her residency in dermatology at the University of Washington in 2002; and then remained at the University of Washington as an assistant professor until 2004. The majority of Dr. Asgari’s time is now spent doing clinical research with a focus on preventing skin cancer. Her research is funded by the National Institutes of Health.

In order to treat skin cancer with the highest possible cure rate, Dr. Asgari trained as a Mohs surgeon at the University of Texas Southwestern Medical Center in 2004 to 2005. The Mohs technique allows for the examination of all of the surgical margins at the time of the surgery prior to closure.

Current Position(s):

  • Research Scientist II, Division of Research, Kaiser Permanente Northern California
  • Associate Physician, Department of Dermatology, Kaiser Permanente Walnut Creek, CA
  • Clinical Assistant Professor, Department of Dermatology, University of California, San Francisco

Primary Research Interests:

  • Treatment and prevention of skin cancer
  • Patient satisfaction in skin cancer treatment
Loading...

Validation of Keratinocyte Carcinoma Registry at Kaiser Permanente

The goal is to develop a population-based registry of KPNC members diagnosed with keratinocyte carcinoma as identified by Systemized Nomenclature of Medicine (SNOMED) codes assigned electronically at time of pathology diagnosis.
Funder: National Cancer Institute
Principal Investigator: Asgari, Maryam

Loading...

HIV Infection, Immunodeficiency and Skin Cancer

The goald is to: 1. To compare the tumor subtype (basal cell carcinoma, squamous cell carcinoma, and melanoma) and location (sun exposed vs. non-sunexposed) between HIV-infected persons and HIV-uninfected persons with skin cancer. 2. To compare the risk of skin cancer between those with and without HIV infection. 3.  To determine the association of immunodeficiency and skin cancer risk. 4. To compare the tumor invasiveness of cancers according to HIV infection status and level of immunodeficiency.
Funder: Kaiser Permanente Community Benefit Program
Principal Investigator: Asgari, Maryam

Loading...

Comparing Characteristics of CRN Melanoma Cases to the National SEER Database

The goal is to determine if melanoma incidence and mortality trends as well as patient, tumor, and care characteristics in HMO settings (KPNC and HFHS) are reflective of the national population, and to adjust for difference if they exist, so inferences can be made about the generalizability of study findings and congruency of melanoma trends.
Funder: National Cancer Institute
Principal Investigator: Asgari, Maryam

Loading...

Randomized Screening Trial for Melanoma in a Large Cancer Research Network

The specific aims of this project are to produce a state-of-the-art, web-based educational program for primary care clinicians (PCCs) to screen for skin cancer by full body skin examination (FBSE).
Funder: Melanoma Research Alliance
Principal Investigator: Asgari, Maryam

Loading...

A Database Cohort Study to Assess the Risk of Non-melanoma Skin Cancer in Adult Patients with Atopic Dermatitis Exposed to Topical Calcineurin Inhibitors

This study presents a revised approach to assessing the long-term risk of non-melanoma skin cancer (NMSC) in adult patients aged ≥ 40 years of age with atopic dermatitis (AD) exposed to topical calcineurin inhibitors.
Funder: Novartis
Principal Investigator: Asgari, Maryam

Loading...

NSAID Use in Chemoprevention of Squamous Cell Carcinomas

This research is focused on epidemiological studies, examining the association between use of nonsteroidal anti-inflammatory drugs (NSAIDs) and the development of cutaneous squamous cell carcinomas (SCCs) using two population-based study designs. 
Funder: Nat. Inst. of Arthritis & Musc-skel & Skin Disease
Principal Investigator: Asgari, Maryam